- Research works
- 42 ▲ 34% vs 2013–17
- Citations
- 823 19.6 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 34% world 28%
Not ranked overall: Geistlich Pharma (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Dentistry, 9.2×. Every wedge is a field page.
Which keywords describe research at Geistlich Pharma (Switzerland)?
By fractional works in all years, weighted toward what it does more of than the world: Biomaterials, Tissue Engineering, Bone Regeneration, Regenerative Medicine, Synthesis, Consumer Protection, Growth Factors and Digital Markets Act.
- Regeneration
- Medical Gases
- Triazines
- Microwave-Assisted Synthesis
- Tubulin Inhibitors
- Regulatory Competition
- European Company Law
- Scaffold
- Peri-implant Diseases
- Dental Implants
- Scaffolds
- Biological Evaluation
- Inflammation
- Orthopedic Surgery
- Anticancer Agents
- Platelet-Rich Plasma
- Digital Markets Act
- Consumer Protection
- Regenerative Medicine
- Tissue Engineering
- Biomaterials
- Bone Regeneration
- Synthesis
- Growth Factors
- EU Competition Law
- Angiogenesis
- Antimicrobial
- Tissue Regeneration
- Anticancer
- Hydroxyapatite
- Heterocyclic Compounds
- Legal Transplants
- Drug Discovery
- Medicinal Chemistry
- Heterocycles
- Thermodynamics
- Vascular Targeting Agents
- Molecular Docking
- Anaesthesia
- Extracellular Matrix
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Biomaterials6▲ 67×4 topics
- Tissue Engineering5▲ 22×7 topics
- Bone Regeneration5▲ 105×2 topics
- Regenerative Medicine4▲ 50×4 topics
- Synthesis3▲ 14×5 topics
- Consumer Protection3▲ 165×2 topics
- Growth Factors3▲ 72×3 topics
- Digital Markets Act3▲ 916×1 topic
- EU Competition Law3▲ 916×1 topic
- Platelet-Rich Plasma3▲ 111×2 topics
- Angiogenesis3▲ 16×4 topics
- Anticancer Agents3▲ 27×4 topics
- Antimicrobial3▲ 25×5 topics
- Orthopedic Surgery3▲ 126×1 topic
- Tissue Regeneration3▲ 199×1 topic
- Inflammation3▲ 2.6×12 topics
- Anticancer2▲ 30×4 topics
- Biological Evaluation2▲ 46×3 topics
- Hydroxyapatite2▲ 100×1 topic
- Scaffolds2▲ 100×1 topic
- Heterocyclic Compounds2▲ 35×3 topics
- Dental Implants2▲ 112×1 topic
- Legal Transplants2▲ 138×2 topics
- Peri-implant Diseases2▲ 112×1 topic
- Drug Discovery2▲ 12×3 topics
- Scaffold2▲ 51×2 topics
- Medicinal Chemistry2▲ 13×2 topics
- European Company Law2▲ 200×1 topic
- Heterocycles2▲ 26×3 topics
- Regulatory Competition2▲ 200×1 topic
- Thermodynamics2▲ 42×2 topics
- Tubulin Inhibitors2▲ 75×1 topic
- Vascular Targeting Agents2▲ 75×1 topic
- Microwave-Assisted Synthesis2▲ 48×2 topics
- Molecular Docking2▲ 26×1 topic
- Triazines2▲ 90×1 topic
- Anaesthesia1▲ 162×1 topic
- Medical Gases1▲ 162×1 topic
- Extracellular Matrix1▲ 11×4 topics
- Regeneration1▲ 15×4 topics
Which research topics does Geistlich Pharma (Switzerland) publish most on?
By volume in 2022–2025: Corporate Governance and Law, Diverse Legal and Medical Studies, Taxation and Legal Issues and Periodontal Regeneration and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Corporate Governance and Law Strategy and Management 1 works
- 2 Diverse Legal and Medical Studies Strategy and Management 0 works
- 3 Taxation and Legal Issues Accounting 0 works
- 4 Periodontal Regeneration and Treatments Urology 0 works
- 5 Bone Tissue Engineering Materials Biomedical Engineering 0 works
- 6 3D Printing in Biomedical Research Biomedical Engineering 0 works
- 7 Dental Implant Techniques and Outcomes Oral Surgery 0 works
- 8 Law and Political Science Law 0 works
- 9 Wound Healing and Treatments Rehabilitation 0 works
- 10 Digitalization, Law, and Regulation Law 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Geistlich Pharma (Switzerland)'s research output changed?
Output in 2018–2022 was 34% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Wolhusen
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.